OTCPK:AMBF.F

Stock Analysis Report

Executive Summary

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally.

Snowflake

Fundamentals

High growth potential with solid track record.


Similar Companies

Share Price & News

How has Ambu's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:AMBF.F

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

-41.1%

OTCPK:AMBF.F

9.7%

US Medical Equipment

1.9%

US Market

AMBF.F underperformed the Medical Equipment industry which returned 9.7% over the past year.

AMBF.F underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

AMBF.FIndustryMarket
7 Day0%1.5%0.8%
30 Day15.9%0.7%3.4%
90 Day26.4%2.4%2.1%
1 Year-41.1%-41.1%10.6%9.7%4.2%1.9%
3 Yearn/a70.2%65.0%46.7%37.2%
5 Yearn/a136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Ambu's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Ambu undervalued based on future cash flows and its price relative to the stock market?

54.58x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Ambu's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Ambu's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Ambu is overvalued based on earnings compared to the US Medical Equipment industry average.

Ambu is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Ambu is poor value based on expected growth next year.


Price Based on Value of Assets

Ambu is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Ambu expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

21.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Ambu's revenue is expected to grow by 15.6% yearly, however this is not considered high growth (20% yearly).

Ambu's earnings are expected to grow significantly at over 20% yearly.

Ambu's revenue growth is expected to exceed the United States of America market average.

Ambu's earnings growth is expected to exceed the United States of America market average.

Ambu's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Ambu is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has Ambu performed over the past 5 years?

24.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Ambu has delivered over 20% year on year earnings growth in the past 5 years.

Ambu's 1-year earnings growth exceeds its 5-year average (62% vs 24%)

Ambu's earnings growth has exceeded the US Medical Equipment industry average in the past year (62% vs 28.2%).


Return on Equity

Ambu has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).


Return on Assets

Ambu used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Ambu's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Ambu's financial position?


Financial Position Analysis

Ambu is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Ambu's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Ambu's level of debt (46.9%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (126.4% vs 46.9% today).

Debt is well covered by operating cash flow (57.1%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 24.1x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1x debt.


Next Steps

Dividend

What is Ambu's current dividend yield, its reliability and sustainability?

0.50%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Ambu's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

Ambu's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).

Ambu is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.

Ambu is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.


Current Payout to Shareholders

No need to calculate the sustainability of Ambu's dividends as it is not paying a notable one for United States of America.


Future Payout to Shareholders

No need to calculate the sustainability of Ambu's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Ambu's salary, the management and board of directors tenure and is there insider trading?

5.5yrs

Average management tenure


CEO

Juan-José Gonzalez (46yo)

0.3yrs

Tenure

0

Mr. Juan-José Gonzalez has been Chief Executive Officer of Ambu A/S since May 15, 2019 and also has been its President since 2019. He is an engineer and MBA graduate and has held a number of senior positio ...


Management Age and Tenure

5.5yrs

Average Tenure

55.5yo

Average Age

The average tenure for the Ambu management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

3.8yrs

Average Tenure

48.5yo

Average Age

The tenure for the Ambu board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Anders Williamsson (65yo)

    Managing Director

    • Tenure: 0yrs
  • Chresten Christensen

    Director General of Ambu S.R.L. & Ambu S.L.

    • Tenure: 0yrs
  • Michael Højgaard (55yo)

    CFO, Executive VP of Global Finance

    • Tenure: 6.7yrs
    • Compensation: ø7.70m
  • Steven Block (56yo)

    CEO & President of USA

    • Tenure: 6.4yrs
  • Keith McCallum

    Managing Director of Ambu UK

    • Tenure: 18.5yrs
  • Henrik Ankjær

    Executive Vice President of Global Operations

    • Tenure: 0.9yrs
  • Johannes Pick

    Managing Director of Ambu GmbH

    • Tenure: 0yrs
  • Måns Barsne

    Executive Vice President of Global Innovation & Chief Innovation Officer

    • Tenure: 4.7yrs
  • Nicolai Thomsen

    IR Manager

    • Tenure: 0yrs
  • Juan-José Gonzalez (46yo)

    President & CEO

    • Tenure: 0.3yrs

Board Members

  • Jens Bager (60yo)

    Chairman of the Board

    • Tenure: 0yrs
  • Christian Sagild (60yo)

    Director

    • Tenure: 7.7yrs
  • Mikael Worning (57yo)

    Vice Chairman

    • Tenure: 0yrs
  • Henrik Wulff (49yo)

    Director

    • Tenure: 3.8yrs
  • Jakob Kristensen (47yo)

    Employee Representative Director

    • Tenure: 6.7yrs
  • Oliver Johansen (48yo)

    Director

    • Tenure: 3.8yrs
  • Thomas Henriksen (46yo)

    Employee Representative Director

    • Tenure: 2.7yrs
  • Jakob Koch (40yo)

    Employee Representative Director

    • Tenure: 2.7yrs

Company Information

Ambu A/S's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ambu A/S
  • Ticker: AMBF.F
  • Exchange: OTCPK
  • Founded: 1937
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: ø28.192b
  • Listing Market Cap: ø4.177b
  • Shares outstanding: 245.04m
  • Website: https://www.ambu.com

Number of Employees


Location

  • Ambu A/S
  • Baltorpbakken 13
  • Ballerup
  • Capital Region of Denmark
  • 2750
  • Denmark

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMBU BCPSE (OMX Nordic Exchange Copenhagen)YesClass B SharesDKDKKAug 1992
AMBF.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDAug 1992
AMBUBCBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBDKKAug 1992
0R4LLSE (London Stock Exchange)YesClass B SharesGBDKKAug 1992
AMBB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDJul 2017

Biography

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally. The company offers anesthesia produc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:08
End of Day Share Price2019/09/10 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.